RecruitingParkinson Disease

PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort

Eligible age

30+ yrs

Accepts

All genders

Locations

19 states

Healthy volunteers

Yes

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

The Parkinson Progression Marker Initiative (PPMI) is a longitudinal, observational, multi-center natural history study to assess progression of clinical features, digital outcomes, and imaging, biologic and genetic markers of Parkinson's disease (PD) progression in study participants with manifest PD, prodromal PD, and healthy controls. The overall goal of PPMI is to identify markers of disease progression for use in clinical trials of therapies to reduce progression of PD disability.

Sponsor: Michael J. Fox Foundation for Parkinson's Research